The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?

Immune checkpoint inhibitors (ICIs) are a novel class of immunotherapy drugs that have improved the treatment of a broad spectrum of cancers as metastatic melanoma, non-small lung cancer or renal cell carcinoma. These humanized monoclonal antibodies target inhibitory receptors (e.g. CTLA-4, PD-1, LA...

Descripción completa

Detalles Bibliográficos
Autores principales: Franzin, Rossana, Netti, Giuseppe Stefano, Spadaccino, Federica, Porta, Camillo, Gesualdo, Loreto, Stallone, Giovanni, Castellano, Giuseppe, Ranieri, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580288/
https://www.ncbi.nlm.nih.gov/pubmed/33162990
http://dx.doi.org/10.3389/fimmu.2020.574271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580288/
https://www.ncbi.nlm.nih.gov/pubmed/33162990
http://dx.doi.org/10.3389/fimmu.2020.574271

Ejemplares similares